Table 1. . Pharmacological properties of dichloroacetate.
| Property | Mechanism | Ref. |
|---|---|---|
| Increased OXPHOS and bioenergetics |
↓ PDK ↑ PDC |
[2,10] |
| Decreased blood glucose in fasting or diabetes |
↓ PDK ↑ PDC |
[4] |
| Decreased blood and CSF lactate |
↓ PDK ↑ PDC |
[19] |
| Decreased blood total and LDL cholesterol |
↓ HMG CoA reductase → ↓ cholesterol synthesis |
[6,7] |
| Decreased blood triglycerides and VLDL cholesterol |
↓ hepatic TG synthesis → ↓ VLDL syntheis |
[4] |
| Reversal of Warburg effect in cancer, PAH and other proliferative conditions | ↓ PDK ↑ PDC | [20] |
CSF: Cerebrospinal fluid; HMG CoA: Hydroxymethylglutaryl coenzyme A; LDL: Low-density lipoprotein; OXPHOS: Oxidative phosphorylation; PAH: Pulmonary arterial hypertension; PDC: Pyruvate dehydrogenase complex; PDK: Pyruvate dehydrogenase kinase; TG: Triglyceride; VLDL: Very low-density lipoprotein.